Current status of distal embolization in percutaneous coronary intervention: Mechanical and pharmacological strategies

Future Cardiology

Volumn 5, Issue 4, 2009, Pages 385-402

  Haeck, Joost D E ^a   Verouden, Niels J W ^a   Henriques, José P S ^a   Koch, Karel T ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

Acute myocardial infarction; Distal embolization; Embolic protection device; Glycoprotein IIb IIIa receptor inhibitor; Microvascular obstruction; Percutaneous coronary intervention; Saphenous vein graft; Thrombectomy device

Indexed keywords

ABCIXIMAB; ACETYLSALICYLIC ACID; ADENOSINE; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CLOPIDOGREL; EPTIFIBATIDE; FIBRINOGEN RECEPTOR ANTAGONIST; FONDAPARINUX; HEPARIN; HIRULOG; NONSTEROID ANTIINFLAMMATORY AGENT; PLACEBO; PROSTAGLANDIN SYNTHASE INHIBITOR; STREPTOKINASE; TIROFIBAN; VASODILATOR AGENT; VERAPAMIL;

ACUTE HEART INFARCTION; ARTIFICIAL EMBOLISM; ATHEROSCLEROTIC PLAQUE; BALLOON OCCLUSION; BLOOD VESSEL OCCLUSION; CLINICAL TRIAL; DIAGNOSTIC IMAGING; EQUIPMENT DESIGN; GUIDE WIRE; HUMAN; INCIDENCE; MICROEMBOLISM; NO REFLOW PHENOMENON; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; REVIEW; THROMBOEMBOLISM; THROMBUS ASPIRATION; TREATMENT OUTCOME; VEIN GRAFT DISEASE;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; ANTICOAGULANTS; CORONARY ANGIOGRAPHY; CORONARY ARTERY BYPASS; EMBOLISM; GRAFT OCCLUSION, VASCULAR; HUMANS; MYOCARDIAL INFARCTION; PLATELET AGGREGATION INHIBITORS; SAPHENOUS VEIN; THROMBECTOMY;

EID: 69549091998     PISSN: 14796678     EISSN: 17448298     Source Type: Journal    
DOI: 10.2217/fca.09.25     Document Type: Review

References (72)

1. Keeley EC, Boura JA, Grines CL: Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials. Lancet 361(9351), 13-20 (2003).
2. Henriques JP, Zijlstra F: Frequency and sequelae of ST elevation acute myocardial infarction caused by spontaneous distal embolization from unstable coronary lesions. Am. J. Cardiol. 91(6), 708-711 (2003).
3. Rezkalla SH, Kloner RA: No-reflow phenomenon. Circulation 105(5), 656-662 (2002).
4. Kloner RA, Rude RE, Carlson N et al.: Ultrastructural evidence of microvascular damage and myocardial cell injury after coronary artery occlusion: which comes first? Circulation 62(5), 945-952 (1980).
5. van Gaal WJ, Banning AP: Percutaneous coronary intervention and the no-reflow phenomenon. Expert. Rev. Cardiovasc. Ther. 5(4), 715-731 (2007).
6. Ito H: No-reflow phenomenon and prognosis in patients with acute myocardial infarction. Nat. Clin. Pract. Cardiovasc. Med. 3(9), 499-506 (2006).
7. Kotani J, Nanto S, Mintz GS et al.: Plaque gruel of atheromatous coronary lesion may contribute to the no-reflow phenomenon in patients with acute coronary syndrome. Circulation 106(13), 1672-1677 (2002).
8. Henriques JP, Zijlstra F, Ottervanger JP et al.: Incidence and clinical significance of distal embolization during primary angioplasty for acute myocardial infarction. Eur. Heart J. 23(14), 1112-1117 (2002).
9. Fokkema ML, Vlaar PJ, Svilaas T et al.: Incidence and clinical consequences of distal embolization on the coronary angiogram after percutaneous coronary intervention for ST-elevation myocardial infarction. Eur. Heart J. 30(8), 908-915 (2009).
10. Napodano M, Ramondo A, Tarantini G et al.: Predictors and time-related impact of distal embolization during primary angioplasty. Eur. Heart J. 30(3), 305-313 (2009).
11. Sianos G, Papafaklis MI, Daemen J et al.: Angiographic stent thrombosis after routine use of drug-eluting stents in ST-segment elevation myocardial infarction: the importance of thrombus burden. J. Am. Coll. Cardiol. 50(7), 573-583 (2007).
12. Hiscock M, Oqueli E, Dick R: Percutaneous saphenous vein graft intervention - a review. Heart Lung Circ. 16(Suppl. 3), S51-S55 (2007).
13. Webb JG, Carere RG, Virmani R et al.: Retrieval and ana lysis of particulate debris after saphenous vein graft intervention. J. Am. Coll. Cardiol. 34(2), 468-475 (1999).
14. Coolong A, Baim DS, Kuntz RE et al.: Saphenous vein graft stenting and major adverse cardiac events: a predictive model derived from a pooled ana lysis of 3958 patients. Circulation 117(6), 790-797 (2008).
15. Okamura A, Ito H, Iwakura K et al.: Detection of embolic particles with the Doppler guide wire during coronary intervention in patients with acute myocardial infarction: efficacy of distal protection device. J. Am. Coll. Cardiol. 45(2), 212-215 (2005).
16. Buller CE, Fu Y, Mahaffey KW et al.: ST-segment recovery and outcome after primary percutaneous coronary intervention for ST-elevation myocardial infarction: insights from the Assessment of Pexelizumab in Acute Myocardial Infarction (APEX-AMI) trial. Circulation 118(13), 1335-1346 (2008).
17. McLaughlin MG, Stone GW, Aymong E et al.: Prognostic utility of comparative methods for assessment of ST-segment resolution after primary angioplasty for acute myocardial infarction: the Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) trial. J. Am. Coll. Cardiol. 44(6), 1215-1223 (2004).
18. Moons KG, Klootwijk P, Meij SH et al.: Continuous ST-segment monitoring associated with infarct size and left ventricular function in the GUSTO-I trial. Am. Heart J. 138(3 Pt 1), 525-532 (1999).
19. van't Hof AW, Liem A, de Boer MJ, Zijlstra F: Clinical value of 12-lead electrocardiogram after successful reperfusion therapy for acute myocardial infarction. Zwolle Myocardial infarction Study Group. Lancet 350(9078), 615-619 (1997).
20. Judd RM, Lugo-Olivieri CH, Arai M et al.: Physiological basis of myocardial contrast enhancement in fast magnetic resonance images of 2-day-old reperfused canine infarcts. Circulation 92(7), 1902-1910 (1995).
21. Hirsch A, Nijveldt R, Haeck JD et al.: Relation between the assessment of microvascular injury by cardiovascular magnetic resonance and coronary Doppler flow velocity measurements in patients with acute anterior wall myocardial infarction. J. Am. Coll. Cardiol. 51(23), 2230-2238 (2008).
22. Nijveldt R, Beek AM, Hirsch A et al.: Functional recovery after acute myocardial infarction: comparison between angiography, electrocardiography, and cardiovascular magnetic resonance measures of microvascular injury. J. Am. Coll. Cardiol. 52(3), 181-189 (2008).
23. Silber S, Albertsson P, Aviles FF et al.: Guidelines for percutaneous coronary interventions. The Task Force for Percutaneous Coronary Interventions of the European Society of Cardiology. Eur. Heart J. 26(8), 804-847 (2005).
24. Smith SC Jr, Feldman TE, Hirshfeld JW Jr et al.: ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention - summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to Update the 2001 Guidelines for Percutaneous Coronary Intervention). Circulation 113(1), 156-175 (2006).
25. Gibson CM, Zorkun C, Kunadian V: Intracoronary administration of abciximab in ST-elevation myocardial infarction. Circulation 118(1), 6-8 (2008).
26. Lee KW, Norell MS: Management of 'no-reflow' complicating reperfusion therapy. Acute. Card Care 10(1), 5-14 (2008).
27. Assessment of the Safety and Efficacy of a New Treatment Strategy with Percutaneous Coronary Intervention (ASSENT-4 PCI) investigators: Primary versus tenecteplase-facilitated percutaneous coronary intervention in patients with ST-segment elevation acute myocardial infarction (ASSENT-4 PCI): randomised trial. Lancet 367(9510), 569-578 (2006).
28. Ellis SG, Tendera M, de Belder MA et al.: Facilitated PCI in patients with ST-elevation myocardial infarction. N. Engl. J. Med. 358(21), 2205-2217 (2008).
29. Mehilli J, Kastrati A, Schulz S et al.: Abciximab in patients with acute ST-segment-elevation myocardial infarction undergoing primary percutaneous coronary intervention after clopidogrel loading: a randomized double-blind trial. Circulation 119(14), 1933-1940 (2009).
30. Matsuo A, Inoue N, Suzuki K et al.: Limitations of using a GuardWire temporary occlusion and aspiration system in patients with acute myocardial infarction: multicenter investigation of coronary artery protection with a distal occlusion device in acute myocardial infarction (MICADO). J. Invasive Cardiol. 19(3), 132-138 (2007).
31. Muramatsu T, Kozuma K, Tsukahara R et al.: Comparison of myocardial perfusion by distal protection before and after primary stenting for acute myocardial infarction: Angiographic and clinical results of a randomized controlled trial. Catheter. Cardiovasc. Interv. 70(5), 677-682 (2007).
32. Stone GW, Webb J, Cox DA et al.: Distal microcirculatory protection during percutaneous coronary intervention in acute ST-segment elevation myocardial infarction: a randomized controlled trial. JAMA 293(9), 1063-1072 (2005).
33. Tahk SJ, Choi BJ, Choi SY et al.: Distal protection device protects microvascular integrity during primary percutaneous intervention in acute myocardial infarction: a prospective, randomized, multicenter trial. Int. J. Cardiol. 123(2), 162-168 (2007).
34. Gick M, Jander N, Bestehorn HP et al.: Randomized evaluation of the effects of filter-based distal protection on myocardial perfusion and infarct size after primary percutaneous catheter intervention in myocardial infarction with and without ST-segment elevation. Circulation 112(10), 1462-1469 (2005).
35. Kelbaek H, Terkelsen CJ, Helqvist S et al.: Randomized comparison of distal protection versus conventional treatment in primary percutaneous coronary intervention: the drug elution and distal protection in ST-elevation myocardial infarction (DEDICATION) trial. J. Am. Coll. Cardiol. 51(9), 899-905 (2008).
36. Koch KT, Haeck JD, van der Schaaf RJ et al.: Proximal embolic protection with aspiration in percutaneous corononary intervention using the proxistrade mark device. Rev. Cardiovasc. Med. 8(3), 160-166 (2007).
37. Haeck JD, Koch KT, Bilodeau L et al.: Randomized comparison of primary percutaneous coronary intervention with combined proximal embolic protection and thrombus aspiration and primary percutaneous coronary intervention alone in ST-segment elevation myocardial infarction. Presented at the American College of Cardiology and i2 Summit 2009, Orlando. J. Am. Coll. Cardiol. Suppl. A-28, 2612-2619 (2009).
38. Ali A, Cox D, Dib N et al.: Rheolytic thrombectomy with percutaneous coronary intervention for infarct size reduction in acute myocardial infarction: 30-day results from a multicenter randomized study. J. Am. Coll. Cardiol. 48(2), 244-252 (2006).
39. Antoniucci D, Valenti R, Migliorini A et al.: Comparison of rheolytic thrombectomy before direct infarct artery stenting versus direct stenting alone in patients undergoing percutaneous coronary intervention for acute myocardial infarction. Am. J. Cardiol. 93(8), 1033-1035 (2004).
40. Beran G, Lang I, Schreiber W et al.: Intracoronary thrombectomy with the X-sizer catheter system improves epicardial flow and accelerates ST-segment resolution in patients with acute coronary syndrome: a prospective, randomized, controlled study. Circulation 105(20), 2355-2360 (2002).
41. Lefevre T, Garcia E, Reimers B et al.: X-sizer for thrombectomy in acute myocardial infarction improves ST-segment resolution: results of the X-sizer in AMI for negligible embolization and optimal ST resolution (X AMINE ST) trial. J. Am. Coll. Cardiol. 46(2), 246-252 (2005).
42. Napodano M, Pasquetto G, Sacca S et al.: Intracoronary thrombectomy improves myocardial reperfusion in patients undergoing direct angioplasty for acute myocardial infarction. J. Am. Coll. Cardiol. 42(8), 1395-1402 (2003).
43. De Carlo M, Wood DA, Webb JG et al.: Adjunctive use of the Rinspiration system for fluidic thrombectomy during primary angioplasty: the Rinspiration international registry. Catheter. Cardiovasc. Interv. 72(2), 196-203 (2008).
44. Burzotta F, Trani C, Romagnoli E et al.: Manual thrombus-aspiration improves myocardial reperfusion: the randomized evaluation of the effect of mechanical reduction of distal embolization by thrombus-aspiration in primary and rescue angioplasty (REMEDIA) trial. J. Am. Coll. Cardiol. 46(2), 371-376 (2005).
45. De Luca L, Sardella G, Davidson CJ et al.: Impact of intracoronary aspiration thrombectomy during primary angioplasty on left ventricular remodelling in patients with anterior ST elevation myocardial infarction. Heart 92(7), 951-957 (2006).
46. Silva-Orrego P, Colombo P, Bigi R et al.: Thrombus aspiration before primary angioplasty improves myocardial reperfusion in acute myocardial infarction: the DEAR-MI (Dethrombosis to Enhance Acute Reperfusion in Myocardial Infarction) study. J. Am. Coll. Cardiol. 48(8), 1552-1559 (2006).
47. Kaltoft A, Bottcher M, Nielsen SS et al.: Routine thrombectomy in percutaneous coronary intervention for acute ST-segment-elevation myocardial infarction: a randomized, controlled trial. Circulation 114(1), 40-47 (2006).
48. Ikari Y, Sakurada M, Kozuma K et al.: Upfront thrombus aspiration in primary coronary intervention for patients with ST-segment elevation acute myocardial infarction: report of the VAMPIRE (VAcuuM asPIration thrombus REmoval) trial. JACC Cardiovasc. Interv. 1(4), 424-431 (2008)
49. Svilaas T, Vlaar PJ, van der Horst, I et al.: Thrombus aspiration during primary percutaneous coronary intervention. N. Engl. J. Med. 358(6), 557-567 (2008).
50. Vlaar PJ, Svilaas T, van der Horst I et al.: Cardiac death and reinfarction after 1 year in the Thrombus Aspiration during Percutaneous coronary intervention in Acute myocardial infarction Study (TAPAS): a 1-year follow-up study. Lancet 371(9628), 1915-1920 (2008).
51. Sardella G, Mancone M, Bucciarelli-Ducci C et al.: Thrombus aspiration during primary percutaneous coronary intervention improves myocardial reperfusion and reduces infarct size: the EXPIRA (thrombectomy with export catheter in infarct-related artery during primary percutaneous coronary intervention) prospective, randomized trial. J. Am. Coll. Cardiol. 53(4), 309-315 (2009).
52. De Luca G, Dudek D, Sardella G, Marino P, Chevalier B, Zijlstra F: Adjunctive manual thrombectomy improves myocardial perfusion and mortality in patients undergoing primary percutaneous coronary intervention for ST-elevation myocardial infarction: a meta-ana lysis of randomized trials. Eur. Heart J. 29(24), 3002-3010 (2008).
53. De Luca G, Suryapranata H, Stone GW et al.: Abciximab as adjunctive therapy to reperfusion in acute ST-segment elevation myocardial infarction: a meta-ana lysis of randomized trials. JAMA 293(14), 1759-1765 (2005).
54. Montalescot G, Antoniucci D, Kastrati A et al.: Abciximab in primary coronary stenting of ST-elevation myocardial infarction: a European meta-ana lysis on individual patients' data with long-term follow-up. Eur. Heart J. 28(4), 443-449 (2007).
55. De Luca G, Ucci G, Cassetti E, Marino P: Benefits from small molecule administration as compared with abciximab among patients with ST-segment elevation myocardial infarction treated with primary angioplasty: a meta-analysis. J. Am. Coll. Cardiol. 53(18), 1668-1673 (2009).
56. Thiele H, Schindler K, Friedenberger J et al.: Intracoronary compared with intravenous bolus abciximab application in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention: the randomized Leipzig immediate percutaneous coronary intervention abciximab IV versus IC in ST-elevation myocardial infarction trial. Circulation 118(1), 49-57 (2008).
57. Sezer M, Oflaz H, Goren T et al.: Intracoronary streptokinase after primary percutaneous coronary intervention. N. Engl. J. Med. 356(18), 1823-1834 (2007).
58. Hong MK, Mehran R, Dangas G et al.: Creatine kinase-MB enzyme elevation following successful saphenous vein graft intervention is associated with late mortality. Circulation 100(24), 2400-2405 (1999).
59. Baim DS, Wahr D, George B et al.: Randomized trial of a distal embolic protection device during percutaneous intervention of saphenous vein aorto-coronary bypass grafts. Circulation 105(11), 1285-1290 (2002).
60. Stone GW, Rogers C, Hermiller J et al.: Randomized comparison of distal protection with a filter-based catheter and a balloon occlusion and aspiration system during percutaneous intervention of diseased saphenous vein aorto-coronary bypass grafts. Circulation 108(5), 548-553 (2003).
61. Carrozza JP Jr, Mumma M, Breall JA, Fernandez A, Heyman E, Metzger C: Randomized evaluation of the TriActiv balloon-protection flush and extraction system for the treatment of saphenous vein graft disease. J. Am. Coll. Cardiol. 46(9), 1677-1683 (2005).
62. Mauri L, Cox D, Hermiller J et al.: The PROXIMAL trial: proximal protection during saphenous vein graft intervention using the Proxis Embolic Protection System: a randomized, prospective, multicenter clinical trial. J. Am. Coll. Cardiol. 50(15), 1442-1449 (2007).
63. Kereiakes DJ, Turco MA, Breall J et al.: A novel filter-based distal embolic protection device for percutaneous intervention of saphenous vein graft lesions: results of the AMEthyst randomized controlled trial. JACC Cardiovasc. Interv. 1(3), 248-257 (2008).
64. Roffi M, Mukherjee D, Chew DP et al.: Lack of benefit from intravenous platelet glycoprotein IIb/IIIa receptor inhibition as adjunctive treatment for percutaneous interventions of aortocoronary bypass grafts: a pooled ana lysis of five randomized clinical trials. Circulation 106(24), 3063-3067 (2002).
65. Topol EJ, Yadav JS: Recognition of the importance of embolization in atherosclerotic vascular disease. Circulation 101(5), 570-580 (2000).
66. Michaels AD, Appleby M, Otten MH et al.: Pretreatment with intragraft verapamil prior to percutaneous coronary intervention of saphenous vein graft lesions: results of the randomized, controlled vasodilator prevention on no-reflow (VAPOR) trial. J. Invasive Cardiol. 14(6), 299-302 (2002).
67. Stone GW, Witzenbichler B, Guagliumi G et al.: Bivalirudin during primary PCI in acute myocardial infarction. N. Engl. J. Med. 358(21), 2218-2230 (2008).
68. Wiviott SD, Braunwald E, McCabe CH et al.: Prasugrel versus clopidogrel in patients with acute coronary syndromes. N. Engl. J. Med. 357(20), 2001-2015 (2007).
69. Cura FA, Escudero AG, Berrocal D et al.: Protection of Distal Embolization in High-Risk Patients with Acute ST-Segment Elevation Myocardial Infarction (PREMIAR). Am. J. Cardiol. 99(3), 357-363 (2007).
70. Dudek D, Mielecki W, Legutko J et al.: Percutaneous thrombectomy with the RESCUE system in acute myocardial infarction. Kardiol. Pol. 61(12), 523-533 (2004).
71. De Luca L, Sardella G, Davidson CJ et al.: Impact of intracoronary aspiration thrombectomy during primary angioplasty on left ventricular remodelling in patients with anterior ST elevation myocardial infarction. Heart 92(7), 951-957 (2006).
72. Chevalier B, Gilard M, Lang I et al.: Systematic primary aspiration in acute myocardial percutaneous intervention: a multicentre randomised controlled trial of the export aspiration catheter. EuroIntervention 4(2), 222-228 (2008).